Institutional investors hold a majority ownership of ABBV through the 69.24% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2016, these large investors purchased a net $16.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 76.6 Million shares of AbbVie
COLUMBIA MANAGEMENT INVESTMENT A... Bought 2.8 Million shares of AbbVie
CAPITAL RESEARCH & MANAGEMENT CO... Bought 1.4 Million shares of AbbVie